The Korean government has excluded vaccinations under the age of 30 for new coronavirus vaccines such as AstraZeneca, which have been found to be related to vaccination and blood clots confirmed after vaccination. Decided to resume.
Regarding the vaccine developed by British pharmaceutical giant AstraZeneca and others, EMA = European Pharmaceutical Agency issued a survey result on April 7 that the vaccination may be related to the blood clots confirmed after the vaccination. ..
Regarding this vaccine, the Korean government has postponed vaccination under the age of 60 and has been considering measures based on the opinions of experts, but at a press conference on the afternoon of the 11th, it announced that vaccination will be resumed from the 12th.
Given that EMA and UK regulators say that the benefits of vaccines outweigh the risks, they have decided that it is of utmost importance to promote vaccination and reduce the number of deaths and infections.
However, people under the age of 30 are excluded from vaccination because the benefits are not significant compared to the risk of vaccination.
In addition, we will create a mechanism to detect and treat blood clots at an early stage and promote prompt information sharing.
In South Korea, more than 1.15 million people have been vaccinated at least once, and 75% of the vaccines used are AstraZeneca.